Phase II Trial of Pulse Dosing of Lapatinib in Combination With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly-Diagnosed Glioblastoma Multiforme
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2017
At a glance
- Drugs Lapatinib (Primary) ; Temozolomide (Primary)
- Indications Glioblastoma; Gliosarcoma
- Focus Therapeutic Use
- 17 Aug 2017 Planned End Date changed from 1 Apr 2017 to 7 Dec 2019.
- 17 Aug 2017 Planned primary completion date changed from 1 Apr 2017 to 7 Dec 2018.
- 10 May 2012 New trial record